The CUSUM test applied in prospective nuchal translucency quality review

Ultrasound in Obstetrics and Gynecology

Volumn 37, Issue 5, 2011, Pages 582-587

  Sabria J ^a,d   Barcelo Vidal C ^b   Arigita, M ^c   Jimenez, J M ^c   Puerto, B ^c   Borrell, A ^c  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

CUSUM; Down syndrome; nuchal translucency; prenatal screening; quality assurance

Indexed keywords

ARTICLE; EDUCATION; FEMALE; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; OBSTETRICS; PREGNANCY; PROSPECTIVE STUDY; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; STANDARD;

FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; OBSTETRICS; PREGNANCY; PROSPECTIVE STUDIES; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY;

EID: 79955383715     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.8860     Document Type: Article

References (13)

1. th edn), Milunski A, (ed.). Johns Hopkins University Press: Baltimore, MA, 2004; 795-835.
2. Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH,. Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 33: 657-664.
3. Fetal Medicine Foundation website. [Accessed 1 May 2010].
4. D'Alton ME, Cleary-Goldman J, Lambert-Messerlian G, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, Dukes K, Canick JA, Malone FD,. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial. Ultrasound Obstet Gynecol 2009; 33: 142-146.
5. Wojdemann KR, Christiansen M, Sundberg K, Larsen SO, Shalmi A, Tabor A,. Quality assessment in prospective nuchal translucency screening for Down syndrome. Ultrasound Obstet Gynecol 2001; 18: 641-644. (Pubitemid 34063067)
6. Palomaki GE, Neveux LM, Donnenfeld A, Lee JE, McDowell G, Canick JA, Summers A, Lambert-Messerlian G, Kellner LH, Zebelman A, Haddow JE,. Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective. Genet Med 2008; 10: 131-138. (Pubitemid 351271725)
7. Biau DJ, Porcher R, Salomon LJ,. CUSUM: a tool for ongoing assessment of performance. Ultrasound Obstet Gynecol 2008; 31: 252-255.
8. Nicolaides KH, Snijders RJ, Cuckle HS,. Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn 1998; 18: 519-523. (Pubitemid 28247891)
9. Schmidt P, Staboulidou I, Elsässer M, Vaske B, Hillemanns P, Scharf A,. How imprecise may the measurement of fetal nuchal translucency be without worsening first-trimester screening? Fetal Diagn Ther 2008; 24: 291-295.
10. Evans MI, Van Decruyes H, Nicolaides KH,. Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy. Fetal Diagn Ther 2007; 22: 401-404. (Pubitemid 350014923)
11. Evans MI, Pergament E,. Impact of quality of nuchal translucency measurements on detection rates of trisomies 13 and 18. Fetal Diagn Ther 2010; 27: 68-71.
12. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH,. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383.
13. Borrell A, Casals E, Fortuny A, Farre MT, Gonce A, Sanchez A, Soler A, Cararach V, Vanrell JA,. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn 2004; 24: 541-545. (Pubitemid 39061909)